Breast Imaging: Challenges and Opportunities in the Aftermath of the COVID-19 Pandemic

March 08, 2022

In a recent video interview, Amy K. Patel, MD, discussed the aftereffects of delayed breast cancer screening due to the COVID-19 pandemic, keys for improving outreach to underserved communities, legislative wins and challenges, and coalition building to educate and encourage women to resume regular breast cancer screening exams.

Assessing and Implementing Artificial Intelligence in Radiology

February 21, 2022

In a recent video interview, Nina Kottler, MD, discussed the promise of artificial intelligence (AI) for improving workflow efficiency for radiologists, keys to assessing AI vendors and change management principles for facilitating implementation of AI into one’s practice.

Essential Keys to Preventing Burnout in Radiology

February 18, 2022

In a new video presentation, a neuroradiologist discusses steps that individual radiologists can take to reduce the risk of physician burnout as well as actions that group radiology practices can take to increase the engagement of their staff.

Challenging the IDR Process of the No Surprises Act

February 01, 2022

In an exclusive video interview with Diagnostic Imaging, Josh Cooper, vice president of congressional affairs for the American College of Radiology (ACR), and Thomas Hoffman, vice president of legal for the ACR, discuss the ACR’s lawsuit over the IDR process of the No Surprises Act and the potential impact of the law on reimbursement and patient access to care.

Prostate Cancer: Integrating Newer Imaging Modalities Into Clinical Practice

January 31, 2022

Interesting questions raised by a paper that compared the use of 18F-fluciclovine with 68Ga-PSMA-11 imaging modalities to detect biochemical relapse in prostate cancer and implications for integrating newer techniques into clinical practice.

Presentation: Head-to-Head Comparison of 18F-Fluciclovine and 68Ga-PSMA-11 in Prostate Cancer

January 20, 2022

Drs Steven Finkelstein and Louis J. Mazzarelli highlight data revealed in the article “A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT,” by Birgit Pernthaler, et al.